PerkinElmer – Test Kit – New Coronavirus Nucleic Acid Detection Kit
The PerkinElmer New Coronavirus Nucleic Acid Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in human oropharyngeal and nasopharyngeal swab samples.
Available in :
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories.
Technical Specifications
| Package | 45 Tests/Kit | |
| Test Gene Region | ORF1ab & N | |
|---|---|---|
| Sample Type | oropharyngeal swab, nasopharyngeal swab, bronchoalveolar lavage (BAL), sputum, plasma and serum | |
| Sample Volume | 400 µL | |
| Limit of Detection | 20 copies/mL (400 µL) | |
| Specify: No cross-reactivity with common respiratory tract pathogens and blood stream pathogens. Whole system solution (extraction and PCR kits) for blood bank has been tested in Wuhan blood bank | PCR kits have been tested in Beijing CDC and Guangdong CDC. | ||
Key Features
- Specific: Detection of SARS-CoV-2 ORF1ab and N genes
- Sensitive: Limit of detection of 7.14 to 27.24 copies/mL
- Reliable: Performance verified with case studies from outbreak’s point of origin
- Automated: Options available to meet a broad range of sample throughput
With about 11,000 employees serving over 150 countries, PerkinElmer is a $2.3 billion global leader committed to innovating for a…
